Research Paper Volume 11, Issue 23 pp 11416—11439
Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer
Figure 4. Prognostic values of 26 candidate genes in ovarian cancer assessed by Kaplan-Meier plotter database. (A) Prognostic values (overall survival, OS) of the 26 key genes in TCGA ovarian cancer cohort. (B) Prognostic values (relapse free survival, RFS) of the 26 key genes in TCGA ovarian cancer cohort. Green bars indicate a favorable prognosis; red bars indicate an unfavorable prognosis; black bars represent no statistical significance. (C) The detailed information of (A). (D) The detailed information of (B). (E) The prognostic value of GJB2 in 223278_at ovarian cancer cohort. (F) The prognostic value of S100A2 in 204268_at ovarian cancer cohort. (G) The prognostic value of SPOCK2 in 202524_s_at ovarian cancer cohort. (H) The prognostic value of TGM1 in 206008_at ovarian cancer cohort. Logrank P < 0.05 was considered as statistically significant.